The Community PrEP Study to Assess the Acceptance of PrEP Delivered Through CBCT Platforms
Launched by FOUNDATION FOR PROFESSIONAL DEVELOPMENT (PTY) LTD · Jun 5, 2019
Trial Information
Current as of July 22, 2025
Completed
Keywords
ClinConnect Summary
Worldwide, about 1.9 million people became infected with HIV in 2015, most of whom live in Southern and East Africa. In South Africa, the HIV incidence rate among young women ages 15-24 (2.5%) is four times higher than their male counterparts (0.6%). Recent HIV prevention trials in South Africa documented incidence rates of 5-6% per year in 15-24 year old young women. Given this high incidence of HIV, implementing effective HIV prevention strategies - including PrEP - is crucial to controlling HIV globally.
The proposed study leverages existing community-based HIV counseling and testing pl...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Self-identified as female (regardless of assigned sex at birth)
- • 16 - 25 years of age.
- • HIV negative (confirmed during CBCT testing)
- • At risk for HIV acquisition
- • Express interest in taking PrEP
- Exclusion Criteria:
- • Planning to relocate in the next 12 months
- • Positive HIV test at screening or enrolment
- • Pregnant
- • Breastfeeding
- • Current participation in other HIV prevention studies (clinical or behavioural)
- • Current use of ARV drugs for post-exposure prophylaxis (PEP)
- • Presence of any disease or health condition, self-reported or identified by initiation clinician, that may prevent participation.
About Foundation For Professional Development (Pty) Ltd
The Foundation for Professional Development (Pty) Ltd is a distinguished clinical trial sponsor dedicated to advancing medical research and enhancing healthcare outcomes through innovative studies. With a commitment to excellence, the foundation collaborates with healthcare professionals, academic institutions, and industry partners to facilitate high-quality clinical trials across various therapeutic areas. By prioritizing ethical standards, participant safety, and scientific integrity, the foundation aims to contribute valuable insights to the medical community and improve patient care globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
East London, Eastern Cape, South Africa
Patients applied
Trial Officials
Andrew Medina-Marino, PhD
Principal Investigator
Foundation for Professional Development
Linda-Gail Bekker, MBChB, DTMH, DCH, FCP, PhD
Principal Investigator
Desmund Tutu HIV Centre
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials